E-cadherin revealed, in CRC, a significant difference from healthy control group (p < 0.0001), as illustrated in Figure 2A. However, E-cadherin failed to reveal a significant difference between the AP group and both the CRC group (p = 0.1095) and healthy control groups (p < 0.1842). This evidence concerns the gene CDH1 and colorectal carcinoma.